Summary
- Surveyed recently published PBPK applications (January 2025–June 2026) in EMA and FDA assessments
- 10 applications / 27 intended uses
- 63% were reviewed by only one Agency
- 30% received the same assessment from both Agencies
- 7% received different assessment outcomes from the two Agencies
- Key drivers of model inadequacy:
- Insufficient validation, Poor predictive performance, Unjustified assumptions/parameters, Structural/mechanistic concerns
By Xinyuan (Susie) Zhang
ACCP 2026 Annual Meeting, September 27-29, 2026, North Bethesda, Maryland